Thinking of joining a study?

Register your interest

NCT04615026 | COMPLETED | Covid19


Prevalence of Thrombosis in COVID-Patients
Sponsor:

University Hospital Augsburg

Information provided by (Responsible Party):

Alexander Hyhlik-Dürr

Brief Summary:

Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.

Condition or disease

Covid19

Intervention/treatment

duplex sonography

Study Type : OBSERVATIONAL
Estimated Enrollment : 525 participants
Official Title : Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity
Actual Study Start Date : 2020-11-04
Estimated Primary Completion Date : 2021-06-30
Estimated Study Completion Date : 2021-06-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Criteria
Inclusion Criteria
  • * SARS CoV 2 positive swap, at least 4 weeks after infection
Exclusion Criteria
  • * under 18 years old no consent anemia

Prevalence of Thrombosis in COVID-Patients

Location Details

NCT04615026


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Germany,

University Hospital Augsburg

Augsburg, Germany, 86165

Loading...